Panacea Biotec Ltd.

BSE: 531349 | NSE: PANACEABIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE922B01023 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Panacea Biotec Panacea Biotec Ltd. | BSE 377.70 -10.75 (-2.77%) | NSE 377.00 -9.55 (-2.47%) | Trade | Add

BSE Live

Dec 31, 15:00

377.70 -10.75 (-2.77%)

Volume

AVERAGE VOLUME

5-Day

934,545

10-Day

469,607

30-Day

160,854

35,480

Prev. Close

388.45
Open Price

388.75

Bid Price (Qty.)
377.20 (41)
Offer Price (Qty.)
377.95 (417)

NSE Live

Dec 31, 15:00

377.00 -9.55 (-2.47%)

Volume

AVERAGE VOLUME

5-Day

8,114,818

10-Day

4,074,303

30-Day

1,448,547

394,946

Prev. Close

386.55
Open Price

388.00

Bid Price (Qty.)
377.50 (24)
Offer Price (Qty.)
377.75 (2)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Panacea Biotec (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
Per Share Ratios
Basic EPS (Rs.)	-31.72	6.15	-12.41	-9.18	-2.97
Diluted EPS (Rs.)	-31.72	6.15	-12.41	-9.18	-2.97
Cash EPS (Rs.)	-24.72	14.94	-3.09	1.87	8.56
Book Value [ExclRevalReserve]/Share (Rs.)	28.40	55.14	48.34	58.22	70.70
Book Value [InclRevalReserve]/Share (Rs.)	28.40	55.14	48.34	58.22	70.70
Revenue from Operations/Share (Rs.)	88.83	74.56	96.78	88.82	106.54
PBDIT/Share (Rs.)	9.97	-20.69	15.33	17.80	21.54
PBIT/Share (Rs.)	2.91	-29.50	5.98	6.70	9.58
PBT/Share (Rs.)	-28.01	7.91	-10.44	-8.51	-3.09
Net Profit/Share (Rs.)	-31.78	6.13	-12.44	-9.22	-3.40
NP After MI And SOA / Share (Rs.)	-31.72	6.16	-12.08	-8.90	-2.98
Profitability Ratios
PBDIT Margin (%)	11.22	-27.74	15.84	20.03	20.22
PBIT Margin (%)	3.27	-39.56	6.18	7.54	8.99
PBT Margin (%)	-31.53	10.61	-10.78	-9.58	-2.89
Net Profit Margin (%)	-35.77	8.21	-12.85	-10.38	-3.19
NP After MI And SOA Margin (%)	-35.70	8.26	-12.47	-10.01	-2.80
Return on Networth/Equity (%)	-109.75	11.07	-24.73	-15.74	-4.23
Return on Capital Employed (%)	1.90	-41.32	3.99	3.68	4.25
Return on Assets (%)	-13.97	2.74	-4.60	-3.02	-0.98
Total Debt/Equity (X)	3.47	0.31	2.43	2.59	2.45
Asset Turnover Ratio (%)	39.13	33.20	36.87	30.22	35.21
Liquidity Ratios
Current Ratio (X)	1.50	0.54	0.81	1.02	1.16
Quick Ratio (X)	1.18	0.45	0.33	0.56	0.51
Inventory Turnover Ratio (X)	3.68	5.61	1.77	1.72	2.14
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	0.00
Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	0.00
Cash Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	0.00
Coverage Ratios
Interest Coverage Ratios (%)	0.10	-1.72	0.36	0.41	0.46
Interest Coverage Ratios (Post Tax) (%)	0.10	-1.72	0.36	0.41	0.46
Valuation Ratios
Enterprise Value (Cr.)	1,194.59	1,302.99	2,345.39	1,885.47	1,622.21
EV/Net Operating Revenue (X)	2.20	2.85	3.96	3.47	2.48
EV/EBITDA (X)	19.57	-10.28	24.97	17.30	12.28
MarketCap/Net Operating Revenue (X)	1.23	2.66	2.76	1.81	0.87
Retention Ratios (%)	0.00	0.00	0.00	0.00	0.00
Price/BV (X)	3.79	3.56	5.47	2.84	1.32
Price/Net Operating Revenue	1.23	2.66	2.76	1.81	0.87
Earnings Yield	-0.29	0.03	-0.05	-0.06	-0.03